Trial Outcomes & Findings for Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children (NCT NCT00840801)

NCT ID: NCT00840801

Last Updated: 2024-01-19

Results Overview

Percentage of participants achieving NT titer greater than or equal to (\>=) 10.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

302 participants

Primary outcome timeframe

28 days after Vaccination 2

Results posted on

2024-01-19

Participant Flow

The study was conducted from 06 February 2009 to 20 May 2010 in Austria and Czech Republic.

Participant milestones

Participant milestones
Measure	Part A: FSME-IMMUN Participants received FSME-IMMUN (FSME-IMMUN Junior) at Day 0 and 28 as first and second vaccination according to the conventional immunization schedule.	Part A: Encepur Participants received Encepur (Encepur Children) at Day 0 and 28 as first and second vaccination according to the conventional immunization schedule.	Part B: FSME-IMMUN Participants received FSME-IMMUN (FSME-IMMUN Junior) at Day 360 as third vaccination in period 2.
Part A: Screening- Day 28 Postdose 2 STARTED	150	152	0
Part A: Screening- Day 28 Postdose 2 COMPLETED	149	152	0
Part A: Screening- Day 28 Postdose 2 NOT COMPLETED	1	0	0
Part B:Day 28 Postdose2-Day 28 Postdose3 STARTED	0	0	301
Part B:Day 28 Postdose2-Day 28 Postdose3 COMPLETED	0	0	297
Part B:Day 28 Postdose2-Day 28 Postdose3 NOT COMPLETED	0	0	4

Reasons for withdrawal

Reasons for withdrawal
Measure	Part A: FSME-IMMUN Participants received FSME-IMMUN (FSME-IMMUN Junior) at Day 0 and 28 as first and second vaccination according to the conventional immunization schedule.	Part B: FSME-IMMUN Participants received FSME-IMMUN (FSME-IMMUN Junior) at Day 360 as third vaccination in period 2.
Part A: Screening- Day 28 Postdose 2 Screen failure	1	0
Part B:Day 28 Postdose2-Day 28 Postdose3 Lost to Follow-up	0	1
Part B:Day 28 Postdose2-Day 28 Postdose3 Other	0	1
Part B:Day 28 Postdose2-Day 28 Postdose3 Refused blood draw	0	2

Baseline Characteristics

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Part A: FSME-IMMUN n=150 Participants Participants received FSME-IMMUN (FSME-IMMUN Junior) at Day 0 and 28 as first and second vaccination according to the conventional immunization schedule.	Part A: Encepur n=152 Participants Participants received Encepur (Encepur Children) at Day 0 and 28 as first and second vaccination according to the conventional immunization schedule.	Total n=302 Participants Total of all reporting groups
Age, Customized Infants and toddlers (28 days- 23 months)	50 Participants n=5 Participants	50 Participants n=7 Participants	100 Participants n=5 Participants
Age, Customized Children (2-11 years)	100 Participants n=5 Participants	102 Participants n=7 Participants	202 Participants n=5 Participants
Sex: Female, Male Female	77 Participants n=5 Participants	74 Participants n=7 Participants	151 Participants n=5 Participants
Sex: Female, Male Male	73 Participants n=5 Participants	78 Participants n=7 Participants	151 Participants n=5 Participants

PRIMARY outcome

Timeframe: 28 days after Vaccination 2

Population: Per-protocol analysis set included eligible participants who received first and second vaccination; had negative baseline values in NT; had immunogenicity measurements available at baseline; 28 days after second vaccination and no major protocol violations.

Percentage of participants achieving NT titer greater than or equal to (\>=) 10.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=127 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=134 Participants It Included participants who received Encepur during the first and second vaccination.
Seropositivity Rate as Determined by Neutralization Test (NT) 28 Days After the Second Vaccination	100 Percentage of participants Interval 97.1 to 100.0	97.8 Percentage of participants Interval 93.6 to 99.5

SECONDARY outcome

Timeframe: 180 days after the Vaccination 1, 28 days after the Vaccination 3

Population: mITT analysis set included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA(IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA)and NT, had immunogenicity measurements available at baseline and 28 days after second vaccination.

Percentage of participants with NT titer \>=10. Here, "number of participants analyzed" signifies total number of participants included in the modified intent-to-treat (mITT) population and "Number Analyzed" signifies number of participants who were evaluable at specified timeframe.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Seropositivity Rate Determined by NT 180 Days After the First Vaccination and 28 Days After the Third Vaccination 180 Days after Vaccination 1	95.3 Percentage of participants Interval 90.2 to 98.3	91 Percentage of participants Interval 84.8 to 95.3
Seropositivity Rate Determined by NT 180 Days After the First Vaccination and 28 Days After the Third Vaccination 28 Days after Vaccination 3	100 Percentage of participants Interval 97.2 to 100.0	100 Percentage of participants Interval 97.2 to 100.0

SECONDARY outcome

Timeframe: 28 days after Vaccination 2, 180 days after the Vaccination 1, 28 days after the Vaccination 3

Population: mITT analysis set included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA (IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA) and NT, had immunogenicity measurements available at baseline and 28 days after second vaccination.

Percentage of participants with IMMUNOZYM ELISA \>126 Vienna Units per milliliter (VIEU/mL) or Enzygnost ELISA \>10.32 Units per milliliter (U/mL). Here, "Number Analyzed" signifies number of participants who were evaluable at the specified timeframe.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Seropositivity Rate Determined by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 180 Days after Vaccination 1	95.1 percentage of participants Interval 90.1 to 98.0	81.5 percentage of participants Interval 74.2 to 87.4
Seropositivity Rate Determined by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 28 Days after Vaccination 2	100 percentage of participants Interval 97.5 to 100.0	97.3 percentage of participants Interval 93.2 to 99.3
Seropositivity Rate Determined by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 28 Days after Vaccination 3	100 percentage of participants Interval 97.4 to 100.0	100 percentage of participants Interval 97.5 to 100.0

SECONDARY outcome

Timeframe: 28 days after Vaccination 2, 180 days after Vaccination 1, 28 days after Vaccination 3

Population: mITT analysis set included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA (IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA) and NT, had immunogenicity measurements available at baseline and 28 days after second vaccination.

Geometric mean of antibody response measured by NT. Here, "Number Analyzed" signifies number of participants who were evaluable at the specified timeframe.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 180 Days after Vaccination 1	39.7 titer Interval 34.4 to 45.8	25 titer Interval 21.3 to 29.4
Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 28 Days after Vaccination 2	236.8 titer Interval 199.6 to 281.0	118.8 titer Interval 97.5 to 144.9
Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination 28 Days after Vaccination 3	538.2 titer Interval 499.2 to 580.2	521.3 titer Interval 476.6 to 570.2

SECONDARY outcome

Timeframe: 28 days after Vaccination 2, 180 days after Vaccination 1, 28 days after Vaccination 3

Population: mITT analysis set included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA (IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA) and NT, had immunogenicity measurements available at baseline and 28 days after the second vaccination.

Geometric mean of antibody response measured by IMMUNOZYM ELISA (VIEU/mL) and Enzygnost ELISA (U/mL). Here, "Number Analyzed" signifies number of participants who were evaluable at specified timeframe for the specified ELISA assay.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination IMMUNOZYM: 180 Days after Vaccination 1	493.7 titer Interval 436.5 to 558.5	161.2 titer Interval 140.5 to 184.9
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination IMMUNOZYM: 28 Days after Vaccination 2	3026.3 titer Interval 2652.2 to 3453.2	678 titer Interval 561.2 to 819.2
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination IMMUNOZYM: 28 Days after Vaccination 3	11292.9 titer Interval 9693.5 to 13156.3	10508.6 titer Interval 8208.4 to 13453.3
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination Enzygnost: 180 Days after Vaccination 1	47.9 titer Interval 41.4 to 55.4	26.7 titer Interval 22.5 to 31.6
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination Enzygnost: 28 Days after Vaccination 2	163.3 titer Interval 152.8 to 174.5	93.7 titer Interval 81.6 to 107.5
Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination Enzygnost: 28 Days after Vaccination 3	682.2 titer Interval 579.6 to 802.9	673.2 titer Interval 533.4 to 849.7

SECONDARY outcome

Timeframe: 28 days after Vaccination 2, 180 days after Vaccination 1, 28 days after Vaccination 3

Population: mITT analysis set included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA (IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA) and NT, had immunogenicity measurements available at baseline and 28 days after second vaccination.

Geometric mean of fold increase of antibody response measured by NT from day 0 to specified timeframe. Here, "Number Analyzed" signifies number of participants who were evaluable at specified timeframe.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Fold Increase of Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline 180 Days after Vaccination 1	7.9 fold rise Interval 6.8 to 9.1	5 fold rise Interval 4.2 to 5.8
Fold Increase of Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline 28 Days after Vaccination 3	106.7 fold rise Interval 98.5 to 115.5	103.5 fold rise Interval 94.6 to 113.2
Fold Increase of Antibody Response Measured by NT 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline 28 Days after Vaccination 2	46.9 fold rise Interval 39.5 to 55.8	23.6 fold rise Interval 19.4 to 28.8

SECONDARY outcome

Timeframe: 28 days after Vaccination 2, 180 days after Vaccination 1, 28 days after Vaccination 3

Population: mITT population included eligible participants who fulfilled all inclusion and exclusion criteria, received first and second vaccination, had no positive baseline values in ELISA (IMMUNOZYM FSME ELISA and Enzygnost TBE ELISA) and NT, had immunogenicity measurements available at baseline and 28 days after the second vaccination.

Geometric mean of fold increase of antibody response measured by IMMUNOZYM ELISA (VIEU/ml) and Enzygnost ELISA (U/ml) from day 0 to specified timeframe. Here, "Number Analyzed" signifies number of participants who were evaluable at the specified timeframe for the specified ELISA assay.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=149 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline IMMUNOZYM: 180 Days after Vaccination 1	31.6 fold rise Interval 26.8 to 37.2	9.5 fold rise Interval 8.1 to 11.0
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline IMMUNOZYM: 28 Days after Vaccination 2	193.7 fold rise Interval 163.0 to 230.1	39.9 fold rise Interval 32.5 to 49.0
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline IMMUNOZYM: 28 Days after Vaccination 3	719.9 fold rise Interval 591.5 to 876.3	620.9 fold rise Interval 479.7 to 803.6
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline Enzygnost: 180 Days after Vaccination 1	9.5 fold rise Interval 8.2 to 11.0	5.3 fold rise Interval 4.5 to 6.3
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline Enzygnost: 28 Days after Vaccination 2	32.5 fold rise Interval 30.4 to 34.8	18.7 fold rise Interval 16.3 to 21.5
Fold Increase of Antibody Response Measured by ELISA 28 Days After the Second Vaccination, 180 Days After the First Vaccination and 28 Days After the Third Vaccination as Compared to Baseline Enzygnost: 28 Days after Vaccination 3	135.8 fold rise Interval 115.3 to 160.0	134.6 fold rise Interval 106.7 to 169.9

SECONDARY outcome

Timeframe: Within 28 days after Vaccination 1

Population: The safety analysis set included all participants who received the third vaccination of FSME-IMMUN, after first 2 doses of FSME-IMMUN or Encepur and had documented adverse event information at least immediately afterwards.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=150 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Systemic Reactions Occurring After First Vaccination Systemic reactions: None	136 participants Interval 6.8 to 9.1	134 participants Interval 4.2 to 5.8
Frequency and Severity of Systemic Reactions Occurring After First Vaccination Systemic reactions: Mild	13 participants Interval 39.5 to 55.8	15 participants Interval 19.4 to 28.8
Frequency and Severity of Systemic Reactions Occurring After First Vaccination Systemic reactions: Moderate	1 participants Interval 98.5 to 115.5	3 participants Interval 94.6 to 113.2
Frequency and Severity of Systemic Reactions Occurring After First Vaccination Systemic reactions: Severe	0 participants	0 participants

SECONDARY outcome

Timeframe: Within 28 days after Vaccination 2

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=150 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Systemic Reactions Occurring After Second Vaccination Systemic reactions: None	143 participants Interval 6.8 to 9.1	144 participants Interval 4.2 to 5.8
Frequency and Severity of Systemic Reactions Occurring After Second Vaccination Systemic reactions: Mild	7 participants Interval 39.5 to 55.8	8 participants Interval 19.4 to 28.8
Frequency and Severity of Systemic Reactions Occurring After Second Vaccination Systemic reactions: Moderate	0 participants Interval 98.5 to 115.5	0 participants Interval 94.6 to 113.2
Frequency and Severity of Systemic Reactions Occurring After Second Vaccination Systemic reactions: Severe	0 participants	0 participants

SECONDARY outcome

Timeframe: Within 28 days after Vaccination 3

Systemic symptoms included headache, nausea, vomiting, muscle pain, joint pain, swelling of the lymph nodes, loss of appetite and changes in sleeping behavior in all age strata; restlessness in children 1 to 2 years of age; malaise and fatigue in participants 3 to 11 years of age as collected in participant diary. Number of participants with systemic reactions according to severity after third vaccination were reported. Here, "number of participants analyzed" signifies those participants who received FSME-IMMUN or Encepur during the first and second vaccination and received FSME-IMMUN at Day 360 as third vaccination.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=298 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Systemic Reactions Occurring After Third Vaccination Systemic reactions: None	282 participants Interval 6.8 to 9.1	—
Frequency and Severity of Systemic Reactions Occurring After Third Vaccination Systemic reactions: Mild	15 participants Interval 39.5 to 55.8	—
Frequency and Severity of Systemic Reactions Occurring After Third Vaccination Systemic reactions: Moderate	1 participants Interval 98.5 to 115.5	—
Frequency and Severity of Systemic Reactions Occurring After Third Vaccination Systemic reactions: Severe	0 participants	—

SECONDARY outcome

Timeframe: Within 6 days of Vaccination 1

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=150 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Injection Site Reactions Occurring After the First Vaccination None	131 participants Interval 6.8 to 9.1	108 participants Interval 4.2 to 5.8
Frequency and Severity of Injection Site Reactions Occurring After the First Vaccination Unknown	1 participants Interval 39.5 to 55.8	0 participants Interval 19.4 to 28.8
Frequency and Severity of Injection Site Reactions Occurring After the First Vaccination Mild	18 participants Interval 98.5 to 115.5	41 participants Interval 94.6 to 113.2
Frequency and Severity of Injection Site Reactions Occurring After the First Vaccination Moderate	0 participants	3 participants
Frequency and Severity of Injection Site Reactions Occurring After the First Vaccination Severe	0 participants	0 participants

SECONDARY outcome

Timeframe: Within 6 days of Vaccination 2

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=150 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Injection Site Reactions Occurring After the Second Vaccination None	137 participants Interval 6.8 to 9.1	118 participants Interval 4.2 to 5.8
Frequency and Severity of Injection Site Reactions Occurring After the Second Vaccination Mild	12 participants Interval 98.5 to 115.5	27 participants Interval 94.6 to 113.2
Frequency and Severity of Injection Site Reactions Occurring After the Second Vaccination Moderate	1 participants	7 participants
Frequency and Severity of Injection Site Reactions Occurring After the Second Vaccination Severe	0 participants	0 participants

SECONDARY outcome

Timeframe: Within 6 days of Vaccination 3

Injection site reactions included swelling, induration, redness, injection site pain and tenderness, ecchymosis and hematoma as collected in participant diary. Number of participants with injection site reactions according to severity after third vaccination were reported. Here, "number of participants analyzed" signifies those participants who received FSME-IMMUN or Encepur during the first and second vaccination and received FSME-IMMUN at Day 360 as third vaccination.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=298 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Injection Site Reactions Occurring After the Third Vaccination None	249 participants Interval 6.8 to 9.1	—
Frequency and Severity of Injection Site Reactions Occurring After the Third Vaccination Mild	43 participants Interval 39.5 to 55.8	—
Frequency and Severity of Injection Site Reactions Occurring After the Third Vaccination Moderate	4 participants Interval 98.5 to 115.5	—
Frequency and Severity of Injection Site Reactions Occurring After the Third Vaccination Severe	2 participants	—

SECONDARY outcome

Timeframe: Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before Vaccination 3

An AE was any untoward medical occurrence in a participants who received study vaccination without regard to possibility of causal relationship. A serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent are events between first dose of study vaccine and up to one month after last dose that were absent before treatment or that worsened relative to pre-treatment state. Number of participants with serious and non-serious adverse events according to severity before third vaccination were reported.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=150 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur n=152 Participants It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Non-Serious AE: within 28 days after Vaccination 1	57 participants Interval 6.8 to 9.1	80 participants Interval 4.2 to 5.8
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Serious AE: within 28 days after Vaccination 1	1 participants Interval 39.5 to 55.8	0 participants Interval 19.4 to 28.8
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Non-Serious AE: within 28 days after Vaccination 2	42 participants Interval 98.5 to 115.5	66 participants Interval 94.6 to 113.2
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Serious AE: within 28 days after Vaccination 2	0 participants	0 participants
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Non-Serious AE:after Part A to before Vaccination3	97 participants	102 participants
Frequency and Severity of Adverse Events (AE) Observed Before the Third Vaccination Serious AE: after Part A to before Vaccination 3	6 participants	10 participants

SECONDARY outcome

Timeframe: Within 28 days after Vaccination 3

An AE was any untoward medical occurrence in a participants who received study vaccination without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability / incapacity; congenital anomaly. Treatment-emergent are events between first dose of study vaccine and up to one month after last dose that were absent before treatment or that worsened relative to pre-treatment state. Number of participants with serious and non-serious adverse events according to severity after third vaccination were reported. Here, "number of participants analyzed" signifies those participants who received FSME-IMMUN or Encepur during the first and second vaccination and received FSME-IMMUN at Day 360 as third vaccination.

Outcome measures

Outcome measures
Measure	FSME-IMMUN n=298 Participants It Included participants who received FSME-IMMUN during the first and second vaccination.	Encepur It Included participants who received Encepur during the first and second vaccination.
Frequency and Severity of Adverse Events (AE) Observed After the Third Vaccination Serious AE: within 28 days after Vaccination 3	0 participants Interval 39.5 to 55.8	—
Frequency and Severity of Adverse Events (AE) Observed After the Third Vaccination Non-Serious AE: within 28 days after Vaccination 3	102 participants Interval 6.8 to 9.1	—

Adverse Events

Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 1

Serious events: 1 serious events

Other events: 17 other events

Deaths: 0 deaths

Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 2

Serious events: 0 serious events

Other events: 13 other events

Deaths: 0 deaths

Part B (1-2 Years of Age) FSME-IMMUN: Before Vaccination 3

Serious events: 1 serious events

Other events: 37 other events

Deaths: 0 deaths

Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 1

Serious events: 0 serious events

Other events: 15 other events

Deaths: 0 deaths

Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 2

Serious events: 0 serious events

Other events: 11 other events

Deaths: 0 deaths

Part B (3-6 Years of Age) FSME-IMMUN: Before Vaccination 3

Serious events: 3 serious events

Other events: 30 other events

Deaths: 0 deaths

Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 1

Serious events: 0 serious events

Other events: 14 other events

Deaths: 0 deaths

Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 2

Serious events: 0 serious events

Other events: 10 other events

Deaths: 0 deaths

Part B (7-11 Years of Age) FSME-IMMUN: Before Vaccination 3

Serious events: 2 serious events

Other events: 30 other events

Deaths: 0 deaths

Part A (1-2 Years of Age) Encepur: After Vaccination 1

Serious events: 0 serious events

Other events: 25 other events

Deaths: 0 deaths

Part A (1-2 Years of Age) Encepur: After Vaccination 2

Serious events: 0 serious events

Other events: 13 other events

Deaths: 0 deaths

Part B (1-2 Years of Age) Encepur: Before Vaccination 3

Serious events: 4 serious events

Other events: 39 other events

Deaths: 0 deaths

Part A (3-6 Years of Age) Encepur: After Vaccination 1

Serious events: 0 serious events

Other events: 33 other events

Deaths: 0 deaths

Part A (3-6 Years of Age) Encepur: After Vaccination 2

Serious events: 0 serious events

Other events: 19 other events

Deaths: 0 deaths

Part B (3-6 Years of Age) Encepur: Before Vaccination 3

Serious events: 3 serious events

Other events: 33 other events

Deaths: 0 deaths

Part A (7-11 Years of Age) Encepur: After Vaccination 1

Serious events: 0 serious events

Other events: 30 other events

Deaths: 0 deaths

Part A (7-11 Years of Age) Encepur: After Vaccination 2

Serious events: 0 serious events

Other events: 26 other events

Deaths: 0 deaths

Part B (7-11 Years of Age) Encepur: Before Vaccination 3

Serious events: 3 serious events

Other events: 30 other events

Deaths: 0 deaths

Part B (1-2 Years of Age) FSME-IMMUN: After Vaccination 3

Serious events: 0 serious events

Other events: 23 other events

Deaths: 0 deaths

Part B (3-6 Years of Age) FSME-IMMUN: After Vaccination 3

Serious events: 0 serious events

Other events: 29 other events

Deaths: 0 deaths

Part B (7-11 Years of Age) FSME-IMMUN: After Vaccination 3

Serious events: 0 serious events

Other events: 30 other events

Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure	Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 1 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 2 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (1-2 Years of Age) FSME-IMMUN: Before Vaccination 3 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 1 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 2 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (3-6 Years of Age) FSME-IMMUN: Before Vaccination 3 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 1 n=49 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 2 n=49 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (7-11 Years of Age) FSME-IMMUN: Before Vaccination 3 n=48 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (1-2 Years of Age) Encepur: After Vaccination 1 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (1-2 Years of Age) Encepur: After Vaccination 2 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (1-2 Years of Age) Encepur: Before Vaccination 3 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (3-6 Years of Age) Encepur: After Vaccination 1 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (3-6 Years of Age) Encepur: After Vaccination 2 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (3-6 Years of Age) Encepur: Before Vaccination 3 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (7-11 Years of Age) Encepur: After Vaccination 1 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (7-11 Years of Age) Encepur: After Vaccination 2 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (7-11 Years of Age) Encepur: Before Vaccination 3 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part B (1-2 Years of Age) FSME-IMMUN: After Vaccination 3 n=99 participants at risk Participants aged 1 - 2 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.	Part B (3-6 Years of Age) FSME-IMMUN: After Vaccination 3 n=100 participants at risk Participants aged 3 - 6 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.	Part B (7-11 Years of Age) FSME-IMMUN: After Vaccination 3 n=99 participants at risk Participants aged 7 - 11 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.
Congenital, familial and genetic disorders HYPOSPADIAS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Congenital, familial and genetic disorders CRYPTORCHISM	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Ear and labyrinth disorders EUSTACHIAN TUBE DISORDER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations BRONCHITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations HERPANGINA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations OTITIS MEDIA CHRONIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ACUTE TONSILLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations LARYNGITIS	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications FOREIGN BODY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications TRAUMATIC LIVER INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications CONCUSSION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Reproductive system and breast disorders ACQUIRED PHIMOSIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders TONSILLAR HYPERTROPHY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders ADENOIDAL DISORDER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders EPISTAXIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders ADENOIDAL HYPERTROPHY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Surgical and medical procedures ORCHIDOPEXY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).

Other adverse events

Other adverse events
Measure	Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 1 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (1-2 Years of Age) FSME-IMMUN: After Vaccination 2 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (1-2 Years of Age) FSME-IMMUN: Before Vaccination 3 n=50 participants at risk Participants aged 1 - 2 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 1 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (3-6 Years of Age) FSME-IMMUN: After Vaccination 2 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (3-6 Years of Age) FSME-IMMUN: Before Vaccination 3 n=51 participants at risk Participants aged 3 - 6 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 1 n=49 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0, assessed after first vaccination.	Part A (7-11 Years of Age) FSME-IMMUN: After Vaccination 2 n=49 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 28, assessed after second vaccination.	Part B (7-11 Years of Age) FSME-IMMUN: Before Vaccination 3 n=48 participants at risk Participants aged 7 - 11 years who received single dose of 0.25 mL FSME-IMMUN Junior (FSME-IMMUN) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (1-2 Years of Age) Encepur: After Vaccination 1 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (1-2 Years of Age) Encepur: After Vaccination 2 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (1-2 Years of Age) Encepur: Before Vaccination 3 n=50 participants at risk Participants aged 1 - 2 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (3-6 Years of Age) Encepur: After Vaccination 1 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (3-6 Years of Age) Encepur: After Vaccination 2 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (3-6 Years of Age) Encepur: Before Vaccination 3 n=51 participants at risk Participants aged 3 - 6 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part A (7-11 Years of Age) Encepur: After Vaccination 1 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 0, assessed after first vaccination.	Part A (7-11 Years of Age) Encepur: After Vaccination 2 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 28, assessed after second vaccination.	Part B (7-11 Years of Age) Encepur: Before Vaccination 3 n=51 participants at risk Participants aged 7 - 11 years who received single dose of Encepur Children (Encepur) suspension at Day 0 and 28, assessed 28 Days after the second vaccination to prior to third vaccination.	Part B (1-2 Years of Age) FSME-IMMUN: After Vaccination 3 n=99 participants at risk Participants aged 1 - 2 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.	Part B (3-6 Years of Age) FSME-IMMUN: After Vaccination 3 n=100 participants at risk Participants aged 3 - 6 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.	Part B (7-11 Years of Age) FSME-IMMUN: After Vaccination 3 n=99 participants at risk Participants aged 7 - 11 years who received either FSME-IMMUN or Encepur during the first and second vaccination, received FSME-IMMUN Junior (FSME-IMMUN) at Day 360 as third vaccination. Assessment of AEs was done after the third vaccination.
Infections and infestations HERPANGINA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations FUNGAL SKIN INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations GASTROENTERITIS	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations GASTROENTERITIS VIRAL	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations GENITAL CANDIDIASIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations HERPES SIMPLEX	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations IMPETIGO	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations INFLUENZA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations LARYNGITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations NASOPHARYNGITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	13.7% 7/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	12.5% 6/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.0% 5/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	13.7% 7/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	13.7% 7/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ORAL HERPES	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations OTITIS EXTERNA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations OTITIS MEDIA	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	16.0% 8/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.0% 5/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	16.0% 8/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.1% 5/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations OTITIS MEDIA ACUTE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PARONYCHIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PAROTITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PHARYNGITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.1% 3/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	18.8% 9/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	9.8% 5/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	9.8% 5/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 6/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PHARYNGOTONSILLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PNEUMONIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations PSEUDOCROUP	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations RESPIRATORY TRACT INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations RESPIRATORY TRACT INFECTION VIRAL	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations RHINITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations SCARLET FEVER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.2% 2/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations SINUSITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations TONSILLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	20.0% 10/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.4% 5/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	24.0% 12/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations TOOTH INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations TRACHEITIS	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	34.0% 17/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	13.7% 7/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	26.0% 13/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	11.8% 6/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.1% 5/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations UPPER RESPIRATORY TRACT INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 4/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations URINARY TRACT INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations VARICELLA	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	9.8% 5/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations VIRAL INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 4/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.1% 2/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations VIRAL RASH	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations VIRAL TONSILLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations VIRAL UPPER RESPIRATORY TRACT INFECTION	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications ANKLE FRACTURE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications ARTHROPOD BITE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications BURNS SECOND DEGREE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications CLAVICLE FRACTURE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications CONTUSION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications FOREARM FRACTURE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications HEAD INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications HEAT STROKE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications JOINT DISLOCATION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications JOINT INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications JOINT SPRAIN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications LIMB INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications MOUTH INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications MUSCLE STRAIN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications OPEN WOUND	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications SKIN LACERATION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Blood and lymphatic system disorders ANAEMIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Blood and lymphatic system disorders LYMPHADENITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Blood and lymphatic system disorders LYMPHADENOPATHY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Congenital, familial and genetic disorders CRYPTORCHISM	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Ear and labyrinth disorders EAR PAIN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Ear and labyrinth disorders MIDDLE EAR INFLAMMATION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Endocrine disorders THYROIDITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Eye disorders CONJUNCTIVITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Eye disorders CONJUNCTIVITIS ALLERGIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders ABDOMINAL PAIN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders ANAL FISSURE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders APHTHOUS STOMATITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders CONSTIPATION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders DIARRHOEA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders DYSPEPSIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders ENTERITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 4/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders ENTEROCOLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders GASTRITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders NAUSEA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.1% 2/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders STOMATITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders TOOTHACHE	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Gastrointestinal disorders VOMITING	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.1% 3/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders FATIGUE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.1% 3/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.1% 2/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INFLUENZA LIKE ILLNESS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE ERYTHEMA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 4/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 4/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE HAEMATOMA	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE HAEMORRHAGE	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE INDURATION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.1% 2/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.1% 6/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE PAIN	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	20.4% 10/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.2% 5/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 4/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	19.6% 10/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	11.8% 6/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	47.1% 24/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	47.1% 24/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	13.0% 13/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	27.3% 27/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE PRURITUS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders INJECTION SITE SWELLING	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.1% 7/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders MALAISE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders PYREXIA	18.0% 9/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.2% 4/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.4% 5/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	18.0% 9/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	9.8% 5/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 8/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
General disorders TENDERNESS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Hepatobiliary disorders HEPATIC STEATOSIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Immune system disorders ALLERGIC OEDEMA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Immune system disorders HYPERSENSITIVITY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Immune system disorders MULTIPLE ALLERGIES	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Immune system disorders SEASONAL ALLERGY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ACUTE SINUSITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ACUTE TONSILLITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.0% 5/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.0% 5/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations BACTERIAL INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations BRONCHOPNEUMONIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations BRONCHITIS	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	8.0% 4/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.2% 3/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations BRONCHITIS BACTERIAL	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations CELLULITIS	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations CONJUNCTIVITIS INFECTIVE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations CYSTITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations EAR INFECTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ENTEROBIASIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations ERYTHEMA INFECTIOSUM	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Infections and infestations EXANTHEMA SUBITUM	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders TRACHEAL PAIN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications THERMAL BURN	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications TRAUMATIC LIVER INJURY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Injury, poisoning and procedural complications WRIST FRACTURE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Investigations BLOOD THYROID STIMULATING HORMONE INCREASED	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Investigations BODY TEMPERATURE INCREASED	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Investigations HEART RATE INCREASED	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Metabolism and nutrition disorders DECREASED APPETITE	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Metabolism and nutrition disorders HYPERGLYCAEMIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Metabolism and nutrition disorders OBESITY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Metabolism and nutrition disorders UNDERWEIGHT	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Musculoskeletal and connective tissue disorders ARTHRALGIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Musculoskeletal and connective tissue disorders ARTHRITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Musculoskeletal and connective tissue disorders FOOT DEFORMITY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Musculoskeletal and connective tissue disorders MYALGIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 2/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Musculoskeletal and connective tissue disorders PAIN IN EXTREMITY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Neoplasms benign, malignant and unspecified (incl cysts and polyps) MELANOCYTIC NAEVUS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Nervous system disorders HEADACHE	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	12.2% 6/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.1% 3/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.8% 4/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	9.8% 5/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.0% 3/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	7.1% 7/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Psychiatric disorders ATTENTION DEFICIT/HYPERACTIVITY DISORDER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Psychiatric disorders RESTLESSNESS	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	10.0% 5/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Psychiatric disorders SLEEP DISORDER	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Psychiatric disorders TIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Renal and urinary disorders HAEMATURIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Renal and urinary disorders MICTURITION DISORDER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Reproductive system and breast disorders ACQUIRED PHIMOSIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Reproductive system and breast disorders BALANITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders ADENOIDAL DISORDER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders ADENOIDAL HYPERTROPHY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders ASTHMA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders COUGH	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.2% 3/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	5.9% 3/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	1.0% 1/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders EPISTAXIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders RHINITIS ALLERGIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Respiratory, thoracic and mediastinal disorders TONSILLAR HYPERTROPHY	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders DERMATITIS	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders DERMATITIS ALLERGIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	3.9% 2/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders DERMATITIS ATOPIC	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders DERMATITIS DIAPER	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	4.0% 2/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	6.0% 3/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders ECZEMA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Skin and subcutaneous tissue disorders URTICARIA	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.1% 1/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).
Surgical and medical procedures TOOTH EXTRACTION	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/49 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/48 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/50 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	2.0% 1/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/51 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/100 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).	0.00% 0/99 • Part A: Within 28 days after Vaccination 1 and Vaccination 2, Part B: 28 days after Vaccination 2 to before the Vaccination 3, within 28 days after Vaccination 3 SAEs and AEs were grouped by system organ class and summarized. AEs included AEs collected in participant diary (local and systemic reactions for FSME-IMMUN) and AEs were documented in participant diary (non-systematic assessment).

Additional Information

Pfizer ClinicalTrials.gov Call Center

Pfizer, Inc.

Phone: 1-800-718-1021

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
Publication restrictions are in place

Restriction type: OTHER